Literature DB >> 8691990

Melatonin inhibits DNA synthesis in MCF-7 human breast cancer cells in vitro.

S Cos1, F Fernández, E J Sánchez-Barceló.   

Abstract

The aim of the present work was to study whether physiological doses of melatonin (1nM) modified DNA synthesis in MCF-7 human breast cancer cells. Exponentially growing MCF-7 cells were incubated for 24 h with thymidine (2mM) for blocking mitosis and synchronizing the cell division cycle. Synchronization was assessed by a flow cytometry study which showed that after release from excess thymidine, 82.3% of the cells were in phase G1. Lots of these synchronized cells were pulsed for 1h with [3H]deoxythymidine ([3H]dThy) or [3H]dThy + melatonin, at 0,3,6,9,12,15 or 24 h from the release of the mitotic arrest. The exposition of these synchronized MCF-7 cells to melatonin for only 1h, significantly inhibited [3H]dThy incorporation when it was at 6 or 9 h. after release from mitotic block, at a time when DNA precursor incorporation was the highest and the number of cells in S phase was maximum. We conclude that, at least in part, melatonin antiproliferative effects on MCF-7 cells could be mediated by a reduction of DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8691990     DOI: 10.1016/0024-3205(96)00249-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Deregulation of HEF1 impairs M-phase progression by disrupting the RhoA activation cycle.

Authors:  Disha Dadke; Michael Jarnik; Elena N Pugacheva; Mahendra K Singh; Erica A Golemis
Journal:  Mol Biol Cell       Date:  2006-01-04       Impact factor: 4.138

2.  Cell cycle-regulated processing of HEF1 to multiple protein forms differentially targeted to multiple subcellular compartments.

Authors:  S F Law; Y Z Zhang; A J Klein-Szanto; E A Golemis
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

3.  Cyclin-dependent kinase-mediated phosphorylation plays a critical role in the oncogenic functions of PELP1.

Authors:  Binoj C Nair; Sujit S Nair; Dimple Chakravarty; Rambabu Challa; Bramanandam Manavathi; P Renee Yew; Rakesh Kumar; Rajeshwar Rao Tekmal; Ratna K Vadlamudi
Journal:  Cancer Res       Date:  2010-08-31       Impact factor: 12.701

4.  SNP rs4971059 predisposes to breast carcinogenesis and chemoresistance via TRIM46-mediated HDAC1 degradation.

Authors:  Zihan Zhang; Xiaoping Liu; Lei Li; Yang Yang; Jianguo Yang; Yue Wang; Jiajing Wu; Xiaodi Wu; Lin Shan; Fei Pei; Jianying Liu; Shu Wang; Wei Li; Luyang Sun; Jing Liang; Yongfeng Shang
Journal:  EMBO J       Date:  2021-08-30       Impact factor: 14.012

Review 5.  Molecular mechanisms of melatonin's inhibitory actions on breast cancers.

Authors:  Sara Proietti; Alessandra Cucina; Russel J Reiter; Mariano Bizzarri
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

6.  Melatonin enhances DNA repair capacity possibly by affecting genes involved in DNA damage responsive pathways.

Authors:  Ran Liu; Alan Fu; Aaron E Hoffman; Tongzhang Zheng; Yong Zhu
Journal:  BMC Cell Biol       Date:  2013-01-07       Impact factor: 4.241

7.  Regulation of rDNA transcription by proto-oncogene PELP1.

Authors:  Vijay K Gonugunta; Binoj C Nair; Rajib Rajhans; Gangadhara R Sareddy; Sujit S Nair; Ratna K Vadlamudi
Journal:  PLoS One       Date:  2011-06-13       Impact factor: 3.240

Review 8.  Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels?

Authors:  E S Schernhammer; K Schulmeister
Journal:  Br J Cancer       Date:  2004-03-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.